Pitcairn’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $649K | Sell |
|
|||||
|
2025
Q1 | $865K | Sell |
|
|||||
|
2024
Q4 | $759K | Sell |
|
|||||
|
2024
Q3 | $974K | Sell |
|
|||||
|
2024
Q2 | $1M | Buy |
|
|||||
|
2024
Q1 | $810K | Buy |
|
|||||
|
2023
Q4 | $727K | Buy |
|
|||||
|
2023
Q3 | $578K | Sell |
|
|||||
|
2023
Q2 | $1.5M | Sell |
|
|||||
|
2023
Q1 | $1.36M | Buy |
|
|||||
|
2022
Q4 | $1.23M | Sell |
|
|||||
|
2022
Q3 | $1.31M | Sell |
|
|||||
|
2022
Q2 | $1.79M | Sell |
|
|||||
|
2022
Q1 | $1.7M | Buy |
|
|||||
|
2021
Q4 | $1.31M | Buy |
|
|||||
|
2021
Q3 | $272K | Sell |
|
|||||
|
2021
Q2 | $335K | Sell |
|
|||||
|
2021
Q1 | $360K | Sell |
|
|||||
|
2020
Q4 | $739K | Sell |
|
|||||
|
2020
Q3 | $865K | Sell |
|
|||||
|
2020
Q2 | $931K | Buy |
|
|||||
|
2020
Q1 | $387K | Sell |
|
|||||
|
2019
Q4 | $364K | Sell |
|
|||||
|
2019
Q3 | $288K | Buy |
|
|||||
|
2019
Q2 | $300K | Sell |
|
|||||
|
2019
Q1 | $320K | Sell |
|
|||||
|
2018
Q4 | $299K | Sell |
|
|||||
|
2018
Q3 | $374K | Sell |
|
|||||
|
2018
Q2 | $331K | Sell |
|
|||||
|
2018
Q1 | $327K | Sell |
|
|||||
|
2017
Q4 | $309K | Buy |
|
|||||
|
2017
Q3 | $303K | Sell |
|
|||||
|
2017
Q2 | $257K | Hold |
|
|||||
|
2017
Q1 | $218K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $257K | Buy |
|
|||||
|
2015
Q3 | $211K | Sell |
|
|||||
|
2015
Q2 | $272K | Sell |
|
|||||
|
2015
Q1 | $267K | Buy |
|
|||||
|
2014
Q4 | $267K | Buy |
|
|||||
|
2014
Q3 | $252K | Sell |
|
|||||
|
2014
Q2 | $213K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $215K | Sell |
|
|||||
|
2013
Q3 | $222K | Sell |
|
|||||
|
2013
Q2 | $249K | Buy |
|